Placeholder

Buserelin acetate

CAS No:
68630-75-1 Category:
  • # LGM Pharma is a Buserelin acetate CAS# 68630-75-1 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Buserelin acetate
  • CAS #: 68630-75-1
  • IUPAC: Luteinizing hormone-releasing factor (pig), 6-(O-(1, 1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate (salt)
  • Formula: C60-H86-N16-O13.C2-H4-O2
  • Molecular Mass: 1299.49
  • Synonyms: 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-O-tert-butyl-D-seryl-L-leucyl-L-arginyl-N-ethyl-L-prolinamide monoacetate (salt), Buserelin acetate, HOE 766, HOE 766 MP, HOE 766MP, Luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-9-(N-ethyl-L-prolinamide)-10-deglycinamide-, monoacetate (salt), Receptal, Suprefact, UNII-13U86G7YSP
  • SMILES: N1C(CC[C@H]1C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1[C@H](C(=O)NCC)CCC1)CCCNC(N)=N)CC(C)C)COC(C)(C)C)=O)Cc1ccc(cc1)O)=O)CO)=O)Cc1c[nH]c2c1cccc2)=O)Cc1cnc[nH]1)=O)=O.CC(=O)O
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants

 

  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service